Metropolis Healthcare Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Metropolis Healthcare Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial public offering of 13,685,095 equity shares of face value of Rs. 2 each (the "equity shares") of the company for cash at a price of Rs. 880 per equity share aggregating Rs. 1204.29 Crores, consisting of an offer for sale of 6,272,335 equity shares by Dr. Sushil Kanubhai Shah (the "promoter selling shareholder") aggregating to 551.97 Crores and 7,412,760 equity shares by Ca Lotus Investments (the "investor selling shareholder") aggregating 652.32 Crores (the "offer"). The offer includes a reservation of up to 300,000 equity shares aggregating up to Rs. 26.40 Crores, for subscription by eligible employees (as defined hereinafter) (the "employee reservation portion"). The offer less the employee reservation portion is hereinafter referred to as the "net offer" and such net offer aggregates to 13,385,095 equity shares. The offer and the net offer shall constitute 27.27% and 26.67%, respectively, of the Post-offer paid-up equity share capital of the company. Offer Price: Rs.880 per equity share of face value of Rs.2 each. Anchor Investor Offer Price: Rs.880 per equity share. The offer price is 440 times the face value.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Company had certain disagreements with ETA Star Healthcare LLC due to which it have not been able to account for the results of its associate, Star Metropolis Health Services Middle East LLC, in its consolidated financial statements since Fiscal 2012 and there is an auditor qualification in its financial statements in this regard.
- Company's business, result of operations and financial condition could be affected by adverse results of legal proceedings.
- Company's inability to effectively manage its growth or to successfully implement its business plan and growth strategy could have an adverse effect on its business, results of operations and financial condition.
- Company inability to protect or use its intellectual property rights or comply with intellectual property rights of others may adversely affect its business.
- Company have commissioned industry report from Frost & Sullivan India Private Limited, which have been used for industry related data in this Prospectus and such data has not been independently verified by it.